Search results
Results from the WOW.Com Content Network
McKesson Europe AG (formerly Celesio AG, previously Gehe AG), with its headquarters in Stuttgart, Germany, is a leading international wholesale and retail company and provider of logistics and services in the pharmaceutical and healthcare sectors. The company had around 37,000 employees at the end of the 2019 financial year (31 March 2019) and ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Help; Learn to edit; Community portal; Recent changes; Upload file
McKesson ANZ is a fully owned subsidiary of McKesson Corporation. McKesson expanded its footprint in Australia and New Zealand by acquiring Emendo in November 2012. [61] McKesson ANZ develops and sells healthcare optimization services and software. The company has traditionally been focused on the public markets in Australia and New Zealand.
Pages for logged out editors learn more. Contributions; Talk; GEHE
Site news – Sources of news about Wikipedia and the broader Wikimedia movement. Teahouse – Ask basic questions about using or editing Wikipedia. Help desk – Ask questions about using or editing Wikipedia. Reference desk – Ask research questions about encyclopedic topics. Content portals – A unique way to navigate the encyclopedia.
This page was last edited on 25 February 2018, at 07:43 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
On March 1, 2001 the new Pharmacy Act was established, allowing free establishment of pharmacies in Norway. At the same time the state decided to not have any ownership in NMD, and sold its part, along with the rest of the owners, to Celesio.
In 2005, Hammergren was elected to Hewlett-Packard's board of directors. [17] Hammergren served until 2013 when he left the board. [18] New York City's public pension funds supported the efforts to oust Hammergren and G. Kennedy Thompson because of their support for the company's 2011 acquisition of British software maker Autonomy and "their failure to protect investors from costly, misguided ...